Track 1

TrenibotulinumtoxinE Rapidly Improves Moderate to Severe Glabellar Lines: Pooled Phase 3 Efficacy and Safety Across East Asian and North American/European Trials

Speaker(s)

• 

  Steven Dayan, MD

  President
  Denova Research